New
ScienceMore in Science→
Targeted gonorrhea therapy defeats resistant strains in lab
Key Takeaways
- Researchers developed an antibody-drug conjugate aimed specifically at gonorrhea bacteria.
- The therapy is activated by an IgA protease enzyme produced by the pathogen.
- A multidrug-resistant strain was eliminated in laboratory testing.
- The work is early-stage and has not yet advanced to human testing.
DE
DT Editorial Team··via phys.org